Okay, let's tackle this question about Phenylketonuria (PKU). The user provided the correct answer but not the options. Hmm. First, I need to recall the main treatment goal for PKU. PKU is an autosomal recessive disorder caused by a deficiency in phenylalanine hydroxylase (PAH), leading to accumulation of phenylalanine. The primary issue here is that phenylalanine builds up, which is toxic to the developing brain, so treatment must prevent that.

The first-line therapy for PKU is dietary management. The main aim is to restrict phenylalanine intake. But wait, maybe the question is about something else, like preventing complications or reducing symptoms. Let me think. The key is to prevent intellectual disability and other neurological issues. So the correct answer would be about maintaining phenylalanine levels within a safe range through diet.

Now, the options might include things like enzyme replacement, medication, or other therapies. But the standard first-line is definitely dietary. So if one of the options is "Restrict phenylalanine intake through diet," that's the right answer. The wrong options could be things like "Increase tyrosine intake," "Administer BH4," or "Use gene therapy." Let me make sure. BH4 (tetrahydrobiopterin) is used in some PKU variants where the defect is in BH4 synthesis, but that's not first-line for classical PKU. Gene therapy is experimental. So the correct answer is dietary restriction.

I need to structure the explanation with the core concept first. The core concept is that PKU requires strict dietary management to prevent phenylalanine accumulation. Then explain why dietary restriction is the main therapy, mentioning PAH deficiency and the role of phenylalanine toxicity. The wrong options would be incorrect because they don't address the primary issue. The clinical pearl would emphasize that early dietary intervention is crucial to prevent irreversible damage. The correct answer is the dietary restriction option.

**Core Concept**
Phenylketonuria (PKU) is an autosomal recessive metabolic disorder caused by deficiency of **phenylalanine hydroxylase (PAH)**, leading to accumulation of phenylalanine. Untreated, it causes neurotoxicity, intellectual disability, and seizures. First-line therapy focuses on **strict dietary restriction of phenylalanine** to prevent these complications.

**Why the Correct Answer is Right**
The primary goal of treatment in PKU is to **limit dietary phenylalanine intake** to maintain serum levels within a safe range (≤2–6 mg/dL). This prevents substrate accumulation and neurotoxicity. A **phenylalanine-restricted diet** (avoiding high-protein foods, using medical formulas) is initiated **immediately after newborn screening** to prevent irreversible brain damage. Lifelong adherence is critical, especially during pregnancy, to avoid fetal harm.

**Why Each Wrong Option is Incorrect**
**Option A:** *Supplement tyrosine* – Tyrosine levels may decrease in PKU due to impaired conversion from phenylalanine, but direct supplementation is not a primary therapy.
**Option B:** *Administer BH4 (tetrahydrobiopterin)* – BH4 is effective in a subset of PKU patients with residual PAH activity or BH4 synthetase deficiency,

✓ Correct Answer: C. Limiting the substrate for deficient enzyme